During HLTH, I spoke with some investors and digital health executives about the types of startups that they haven’t encountered yet — but would like to. The post 3 Types of Startups that Healthcare Leaders Want to See More Of appeared first on MedCity News.
In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers’ challenges in accessing medical data, emphasizing the need for transparency and potential strategies to enhance their fiduciary responsibilities. The post PBGH CEO: Transparency is “Table Stakes” and an “Expectation” appeared first on MedCity News.
As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers. The post Redefining Clinical Development of Obesity Drugs: What Does Success Look Like? appeared first on MedCity News.
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care costs are higher. The post Earlier Detection and Treatment are Essential for Meeting VBC Goals appeared first on MedCity News.
The ability to reduce physician burnout is one of the most exciting things about AI, said CHAI CEO Brian Anderson. In his view, ambient listening AI could end up changing the healthcare delivery world in a similar way that the advent of the sewing machine changed the textile and fashion industry in the 1840s. The…
GoodRx announced a new e-commerce solution starting with over-the-counter birth control pill Opill. It also is offering new affordability programs for menopause medications with Pfizer. The post GoodRx Expands Women’s Health Options with New Birth Control and Menopause Offerings appeared first on MedCity News.
Novo Nordisk’s Wegovy achieved statistically significant improvement in a Phase 3 study in the fatty liver disease MASH. Based on these preliminary results, the company plans to seek U.S. and European Union approvals in this indication in 2025. The post Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA…
Tomorrow’s goal scoring companies will go on offense today by giving an assist to their caregiving team members. The post Create a Winning Playbook for Employee Caregivers appeared first on MedCity News.
To improve outcomes further, healthcare providers will need to take bold action to diagnose and manage this kidney disease before it becomes chronic or fatal. The post Innovations Shaping the Future of Kidney Care appeared first on MedCity News.
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation. The post Heard at HLTH 2024: Insights from Innovative Healthcare Executives appeared first on MedCity News.